Latin America Molecular Diagnostics Market - Opportunity Analysis and Industry Forecasts (2024-2031)

 Meticulous Research®—a leading market research company, published a research report titled, 'Latin America Molecular Diagnostics Market by Offering (Reagents, Kits, Systems, Software, Services), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (HIV, Influenza, HPV, Oncology), End User - Forecast to 2031’

According to this latest publication from Meticulous Research®, the Latin America molecular diagnostics market is projected to reach $2.50 billion by 2031, at a CAGR of 6.3% from 2024 to 2031. The growth of the Latin America molecular diagnostics market is driven by several factors, including the rising global geriatric population, increasing prevalence of communicable & noncommunicable diseases, technological advancements in molecular diagnostics, and rising healthcare expenditures. Factors such as growing scope in emerging economies, increasing focus on companion diagnostics, and the rising popularity of direct-to-consumer (DTC) testing are a few opportunities that would help grow the market in the future. A shortage of skilled professionals could be considered a challenge for the Latin America molecular diagnostics market. However, unfavorable regulatory frameworks and high costs of molecular diagnostic tests restrain the growth of the market.

Key Players: 

The key players profiled in the Latin America molecular diagnostics market report are Bio-Manguinhos (Brazil), F. Hoffmann-La Roche Ltd. (Switzerland), Thermo Fisher Scientific Inc. (U.S.), Hologic, Inc. (U.S.), Illumina, Inc. (U.S.), OmicronLab (Mexico), QIAGEN N.V. (Netherlands), Danaher Corporation (U.S.), Abbott Laboratories (U.S), Agilent Technologies, Inc. (U.S.).

The Latin America molecular diagnostics market is segmented by Offering (Kits & Reagents, Instruments, Software & Services), Test Type (Laboratory Tests and Point-of-Care (POC) Tests), Technology (Polymerase Chain Reaction (PCR), In Situ Hybridization (ISH), Isothermal Nucleic Acid Amplification Technology (INAAT), Microarrays, Sequencing, Mass Spectrometry, and Other Technologies), Application (Infectious Diseases [Respiratory Diseases, Hepatitis, HIV, Chlamydia Trachomatis/Neisseria Gonorrhoeae, Human Papillomavirus (HPV), Healthcare-Associated Infections (HAIs), and Other Infectious Diseases], Oncology [Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Lymphoma, Leukemia, Cervical Cancer, and Other Cancer Types], Genetic Testing, Neurological Diseases, Cardiovascular Diseases, and Other Applications), End User (Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Other End Users). The study also evaluates industry competitors and analyzes the regional and country-level markets.

Among offerings, in 2024, the kits and reagents segment is expected to account for the largest share of the market. The large share of the segment is attributed to the commercial availability of a diverse range of diagnostic reagents & consumables, the availability of diseases-specific test kits & assays, and the growing awareness regarding early disease diagnosis.

Among test types, in 2024, the laboratory test segment is expected to account for the largest share of the market. The large share of the segment is attributed to the large number of laboratory tests available in hospitals, laboratories, and academic & research institutes and also preferred tests by the patients. Additionally, the majority of developments are being done using laboratory tests.

Among technologies, in 2024, the polymerase chain reaction (PCR) segment is expected to account for the largest share of the market. The large share of the segment is attributed to benefits, such as the ability to test multi-drug resistance, its use in several laboratories and clinical techniques, including DNA fingerprinting, detection of bacteria or viruses (particularly AIDS), and diagnosis of genetic disorders.

Among applications, in 2024, the infectious diseases segment is expected to account for the largest share of the market. The large share of the segment is attributed to the rising prevalence of infectious diseases, the increase in funding for the development of new infectious disease diagnostic tools, and the emergence of the COVID-19 pandemic.

Among end users, the hospitals & clinics segment is expected to account for the largest share of the market in 2024. The large share of the segment is attributed to the increased number of hospitalizations due to various diseases requiring molecular diagnosis and the proliferation of hospitals and clinics in emerging countries like Brazil, Chile, Colombia, and Mexico, among others, leading to the growth in the utilization of molecular diagnostic products.

Download Sample of Report @ https://www.meticulousresearch.com/download-sample-report/cp_id=5759

Key questions answered in the report:

·  Which are the high-growth market segments in terms of molecular diagnostics by offering, test type, technology, application, end user, and geography?

·  What was the historical market for molecular diagnostics across Latin America?

·  What are the market forecasts and estimates for the period 2024–2031?

·  What are the major drivers, restraints, opportunities, and challenges in the Latin America molecular diagnostics market?

·  Who are the major players in the Latin America molecular diagnostics market?

·  What is the competitive landscape, and who are the market leaders in the Latin America molecular diagnostics market?

·  What are the recent developments in the Latin America molecular diagnostics market?

·  What are the different strategies adopted by the major players in the Latin America molecular diagnostics market?

·  What are the geographical trends and high-growth regions/countries?

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

Comments

Post a Comment

Popular posts from this blog

The Power Players: 15 Influencing Micro-mobility Market Growth

  The newly published research report on   Micro-mobility Market Report   provides an in-depth comprehension of a rapidly growing market. It offers an extensive market outlook, covering all the major aspects such as Micro-mobility market share, size, trends, projected growth rate, and sales channels. Also, it examines the challenges, opportunities, and prospects for the market. An in-depth analysis of all the major market segments and regions has been provided in the report. Pictorial representations such as tables, graphs, and charts have also been used to help readers comprehend the information easily. Both quantitative and qualitative research methodologies have been used in the study to provide an in-depth market comprehension. It covers crucial information on supply chain challenges and how businesses can deal with them. The research report is a vital resource for stakeholders, investors, and anyone looking to develop effective marketing strategies and stay ahead of ...
Read more

Europe EV Battery Market - Opportunity Analysis And Industry Forecast (2022-2029)

  Meticulous Research®, a prominent market research firm, released a report titled " Europe EV Batteries Market  by Type (Li-ion, Ni-MH, SLA, Ultracapacitors, Solid-state Batteries), Capacity (<50 kWh, 51-100 kWh, 101-300 kWh, >300 kWh), Bonding Type (Wire, Laser), Form, Application, End User, and Country - Forecast to 2029" . The European EV battery market is projected to expand at a compound annual growth rate (CAGR) of 45.8% from 2022, reaching $94.41 billion by 2029 . This growth is primarily fueled by the rising global adoption of electric vehicles, falling battery prices, and the increasing localization of battery production. Additionally, the expanding use of battery-as-a-service presents lucrative growth opportunities for market participants. However, the market's growth may be somewhat hindered by a potential shortage in lithium mining capacity. Additionally, safety concerns related to EV batteries pose a significant challenge to the expansion of t...
Read more

Ventilators Market to be Worth $13.23 Billion by 2031

  Meticulous Research®, a prominent market research firm, released a report titled, ‘ Ventilators Market by Product (Instrument, Catheter, Mask, Tube) Mobility (Intensive Care, Portable) Interface (Invasive, Non-invasive) Age Group (Adult, Neonatal) Mode (Volume, Pressure, Dual) End User (Hospital, ASC, Home Care) – Global Forecast to 2031’. Meticulous Research® predicts that the ventilators market will expand to $13.23 billion by 2031 , growing at a compound annual growth rate (CAGR) of 8.3% between 2024 and 2031. This growth is fuelled by several factors, including the increased availability of intensive care units (ICUs) and ICU beds, higher rates of respiratory diseases, urbanization leading to increased pollution, a growing elderly population, and more instances of preterm births. Nonetheless, obstacles such as the expensive nature of ventilators and the preference for alternative oxygenation therapies hinder market advancement. Rising demand for therapeutic devices for ho...
Read more